Warning Letter Should Not Hinder Taxus Liberté Approval – Boston Scientific
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific estimates it will be ready by June for FDA to re-inspect its facilities to confirm that the quality-control problems cited in a sweeping Jan. 25 warning letter have been fixed